Q3 & FY 2018-19: Financial Statements
Q3 & FY 2018-19: Investor Presentation
Q3 Transcript
Q2 & FY 2018-19: Financial Statements
Q2 & FY 2018-19: Investor Presentation
Q2 Transcript
Q1 & FY 2018-19: Financial Statements
Q1 & FY 2018-19: Investor Presentation
Q1 Transcript
Q4 & FY 2017-18: Financial Statements
Q4 & FY 2017-18: Investor Presentation
Q4 Transcript
Q3 & FY 2017-18: Financial Statements
Q3 & FY 2017-18: Investor Presentation
Q2 FY 2017-18: Financial Statements
Q2 FY 2017-18: Investor Presentation
Q1 FY 2017-18: Financial Statements
Q1 FY 2017-18: Investor Presentation
Q4 & FY 2016-17: Financial Statements
Q4 & FY 2016-17: Investor Presentation
Q3 FY 2016-17: Standalone Financial Results Limited Review Report
Q3 FY 2016-17: Investor Presentation
Annual Report FY 2017-18
AGM Notice FY 2017-18
Sustainability Report 2017-2018
Annual Report FY 2016-17
AGM Notice FY 2016-17
Annual Report FY 2015-16
Annual Report FY 2014-15
Annual Report FY 2013-14
Sriam Labs Pvt Ltd-Audited Financials
Laurus Synthesis Inc Audited Financials INR
Laurus Synthesis Inc Audited Financials USD
Laurus Holdings Ltd Audited Financials INR
Laurus Holdings Ltd Audited Financials GBP
Laurus Generics Inc-Audited Financials
Laurus Generics GmbH-Audited Financials
Laurus Synthesis Inc-Audited Financials
Laurus Synthesis, Inc Audited Financial Statements
We are making great progress on our strategic goals. See our latest annual report.
Download
We are building on our strengths to further extend our product portfolio and target fast-growing segments.
As a science-led pharmaceutical company, we invest in cutting-edge research to develop new cures for challenging diseases.
As a responsible corporate citizen, we will conduct our business with complete respect for the environment and community.
Laurus Generics GmbH 
Laurus Synthesis 
